Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)
China flag China · Delayed Price · Currency is CNY
12.88
+0.02 (0.16%)
At close: Feb 27, 2026

SHE:301126 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
508.8619.85649.4543748.07228.98
Trading Asset Securities
---100--
Cash & Short-Term Investments
508.8619.85649.4643748.07228.98
Cash Growth
26.42%-4.55%1.00%-14.05%226.70%41.28%
Accounts Receivable
2,1831,8171,6931,5381,4471,225
Other Receivables
276.0698.3398118.06110.8389.91
Receivables
2,4591,9151,7911,6561,5581,315
Inventory
921.38858.29629.11433.21250.28286.59
Prepaid Expenses
-4.211.622.550.18-
Other Current Assets
370.45314.13243.29276.9690.4969.79
Total Current Assets
4,2603,7113,3143,0112,6471,900
Property, Plant & Equipment
959.76964.08719.81529.1285.59232.01
Long-Term Investments
65.7123.6122.5320--
Goodwill
1,2691,117717.93174.41--
Other Intangible Assets
130.13135.72138.17103.5525.8326.25
Long-Term Deferred Tax Assets
55.8542.7330.0913.779.797.66
Long-Term Deferred Charges
46.2848.3436.9630.4618.485.57
Other Long-Term Assets
11.2335.01198.148.727.820.86
Total Assets
6,7976,1785,2783,9312,9942,173
Accounts Payable
1,039707.18496.21367.64413.7327.96
Accrued Expenses
32.5650.743.9739.5126.9226.24
Short-Term Debt
2,2371,8841,5211,198589.25585.53
Current Portion of Long-Term Debt
377.76299.0965.1686.6413.67
Current Portion of Leases
-83.348.0926.999.91-
Current Income Taxes Payable
40.3522.2217.3225.4930.3421.66
Current Unearned Revenue
61.4271.8921.1610.9776.1358.61
Other Current Liabilities
119.59185.72341.2159.0114.6710.65
Total Current Liabilities
3,9073,3052,5551,8141,1651,044
Long-Term Debt
863.78885.85833.75211.46106.1486.12
Long-Term Leases
148.01133.49105.6287.2444.11-
Long-Term Unearned Revenue
15.650.040.09---
Long-Term Deferred Tax Liabilities
5.635.511.981.18--
Total Liabilities
4,9404,3293,4962,1141,3151,130
Common Stock
205.4205.4206.51206.51206.51154.88
Additional Paid-In Capital
980.94980.94989.84994.55994.55476.71
Retained Earnings
556.22567.9549.58521.27478.09410.51
Comprehensive Income & Other
2.542.541.3---
Total Common Equity
1,7451,7571,7471,7221,6791,042
Minority Interest
111.5391.9234.4294.9--
Shareholders' Equity
1,8571,8491,7821,8171,6791,042
Total Liabilities & Equity
6,7976,1785,2783,9312,9942,173
Total Debt
3,6263,2862,5741,610753.41685.32
Net Cash (Debt)
-3,118-2,666-1,925-967.4-5.34-456.34
Net Cash Per Share
-15.17-13.04-9.54-4.73-0.03-2.96
Filing Date Shares Outstanding
205.4205.4206.51206.51206.51154.88
Total Common Shares Outstanding
205.4205.4206.51206.51206.51154.88
Working Capital
352.19406.8759.511,1971,482855.87
Book Value Per Share
8.508.558.468.348.136.73
Tangible Book Value
346.4503.76891.131,4441,6531,016
Tangible Book Value Per Share
1.692.454.326.998.016.56
Buildings
-696.23413.71368.48255.49245.15
Machinery
-219.73149.73115.0634.8427.71
Construction In Progress
-25.63151.6826.41.6410.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.